###begin article-title 0
Pin1 Modulates the Type 1 Immune Response
###end article-title 0
###begin p 1
Conceived and designed the experiments: JM SE RB ZS. Performed the experiments: SE RB ZS ZX EH. Analyzed the data: JM SE RB ZS EH RL MS. Wrote the paper: JM SE RB MS.
###end p 1
###begin title 2
Background/Abstract
###end title 2
###begin p 3
###xml 306 315 306 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-trans</italic>
Immune responses initiated by T cell receptor (TCR) and costimulatory molecule mediated signaling culminate in maximal cytokine mRNA production and stability. The transcriptional responses to co-stimulatory T cell signalling involve calcineurin and NF-AT, which can be antagonized by interference with the cis-trans peptidyl-prolyl isomerases (PPIase), cyclophilin A and FKBP. Signalling molecules downstream of CD28 which are essential for the stabilization of cytokine mRNAs are largely unknown.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 316 323 312 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 416 419 <span type="species:ncbi:10116">rat</span>
We now show that Pin1, a third member of the PPIase family mediates the post-transcriptional regulation of Th1 cytokines by activated T cells. Blockade of Pin1 by pharmacologic or genetic means greatly attenuated IFN-gamma, IL-2 and CXCL-10 mRNA stability, accumulation and protein expression after cell activation. In vivo, Pin1 blockade prevented both the acute and chronic rejection of MHC mismatched, orthotopic rat lung transplants by reducing the expression of IFN-gamma and CXCL-10. Combined transcriptional and post-transcriptional blockade with cyclosporine A and the Pin1 inhibitor, juglone, was synergistic.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
These data suggest Pin1 inhibitors should be explored for use as immunosuppressants and employed with available calcineurin inhibitors to reduce toxicity and enhance effectiveness.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 264 267 260 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Haring1">[1]</xref>
###xml 299 302 295 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Yi1">[2]</xref>
###xml 445 448 437 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Schroder1">[3]</xref>
###xml 779 782 763 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Lindstein1">[4]</xref>
###xml 784 787 768 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Mavropoulos1">[5]</xref>
###xml 954 957 938 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Liu1">[6]</xref>
###xml 1053 1062 1037 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-trans</italic>
###xml 1292 1295 1276 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Wulf1">[7]</xref>
###xml 1297 1300 1281 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Zhou1">[8]</xref>
###xml 1396 1399 1380 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Lu1">[9]</xref>
###xml 1543 1547 1527 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Wulf2">[10]</xref>
###xml 1549 1553 1533 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Ayala1">[11]</xref>
###xml 1678 1682 1662 1666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Shen1">[12]</xref>
###xml 1684 1688 1668 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Esnault1">[13]</xref>
###xml 1912 1916 1892 1896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Shaw1">[14]</xref>
###xml 1918 1922 1898 1902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Bakheet1">[15]</xref>
###xml 2025 2029 <span type="species:ncbi:10090">mice</span>
During and after antigen presentation, inflammatory cytokines structure the type and amplitude of the T cell response. Especially important are the type 1 pro-inflammatory cytokines, IFN-gamma, IL-2 and CXCL-10, which are produced in large amounts after infection [1] and during allograft rejection [2]. IL-2 promotes the proliferation and differentiation of T cells whereas IFN-gamma activates immune cells and the antigen presentation pathway [3]. CXCL-10 (IFN-gamma-inducible protein-10) is a potent chemoattractant for inflammatory cells and modulates adhesion molecule expression. The production of IFN-gamma and IL-2 by T cells involves both transcriptional and post-transcriptional regulation with attenuation of either capable of significantly muting cytokine production [4], [5]. The immunosuppressives cyclosporine A (CsA) and FK506 which bind to Cyclophilin A (CyA) and FKBP12, respectively, prevent NF-AT mediated cytokine gene transcription [6]. CyA and FKBP12 are members of the peptidyl-prolyl isomerase (PPIase) family that catalyze the cis-trans isomerization of X-Pro peptide bonds. A third PPIase, Pin1, binds to and isomerizes only phosphorylated Ser/Thr-Pro motifs. Isomerization-induced conformational changes alter target protein function, phosphorylation and turnover [7], [8]. The initially identified Pin1 targets were cell cycle regulators particularly mitotic kinases [9]. Consistent with such a function, overexpression of Pin1 has been observed in many cancers, and its levels are predictive of cancer recurrence [10], [11]. Recently, we implicated Pin1 in the post-transcriptional control of GM-CSF mRNA by activated eosinophils and T lymphocytes [12], [13]. GM-CSF is a prototypical proinflammatory cytokine, whose mRNA is regulated by 3'-untranslated AU-rich elements (AREs). These are also found in and important for the post-transcriptional control of IL-2 and IFN-gamma mRNAs [14], [15] suggesting a role for Pin1 in the type 1 immune response. In the present report, we show that Pin1 KO mice show an alternated cytokine response, after co-stimulation with anti-CD3 and anti-CD28. This reflects an inability of T cells to fully stabilize ARE mRNAs after cell activation. We explore the biology significance of these observations by testing if Pin1 blockade would alter type 1 immune responses to mismatched organ transplants. We show that mismatched lung transplants are not rejected if Pin1 is inhibited. Further, we show that Pin1 blockade is synergistic with calcineurin inhibitors such as Cyclosporin A. These data establish a new role for Pin1 in the T cell immune response and point to a novel target for immunosuppression.
###end p 9
###begin title 10
Results
###end title 10
###begin p 11
###xml 240 243 240 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Lindstein1">[4]</xref>
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Esnault1">[13]</xref>
###xml 427 436 423 432 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 1A</bold>
###xml 427 436 423 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g001"><bold>figure 1A</bold></xref>
###xml 555 564 547 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 1B</bold>
###xml 555 564 547 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g001"><bold>figure 1B</bold></xref>
###xml 696 705 684 693 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 1C</bold>
###xml 696 705 684 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g001"><bold>figure 1C</bold></xref>
###xml 927 936 915 924 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">not shown</bold>
###xml 1393 1402 1377 1386 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 1D</bold>
###xml 1393 1402 1377 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g001"><bold>figure 1D</bold></xref>
###xml 1402 1415 1386 1399 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and not shown</bold>
###xml 1573 1577 1553 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Lu2">[16]</xref>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
###xml 995 999 <span type="species:ncbi:10090">mice</span>
Pin1 function on type 1 cytokine and chemokine expression was first evaluated in Pin1 knockout (KO) mice. Splenocytes from KO mice activated with anti-CD3 plus anti-CD28, which normally triggers cytokine mRNA stabilization and accumulation [4], [13], showed significantly less IFN-gamma and IL-2 mRNA compared to WT (p<0.03 and p<0.008, respectively) while CXCL-10 mRNA was reduced by 50% but did not quite reach significance (figure 1A). Secreted IFN-gamma was proportionally reduced (4-fold) in the supernatant of KO splenocyte cultures compared to WT (figure 1B). Bulk analysis of activated KO CD4+ or CD8+ splenocytes by flow cytometry showed reductions in IL-2 and IFN-gamma positive cells (figure 1C) compared to splenocytes from heterozygote mice. In KO mice, no differences were noted in the numbers of splenic or thymic CD3, CD4, CD8 or regulatory T cell populations or activation marker expression after stimulation (not shown), eliminating developmental differences between WT and KO mice. As CD3 mediated signaling is necessary for T cell development, these data suggest TCR function is likely normal in Pin1 KO animals. Instead, these data suggested Pin1 was involved in co-stimulatory-CD3/CD28 signaling. Indeed, IFN-gamma and IL-2 mRNAs were less stable in anti-CD3/anti-CD28 activated KO than WT splenocytes while the stability of CXCL-10 mRNA, which lacks AREs was unchanged (figure 1Dand not shown). Therefore, Pin1 is necessary for ARE mediated cytokine mRNA stabilization after T cell co-stimulation. As Pin1 substrates also include NF-kappaB and NF-AT [16], which regulate cytokine mRNA transcription, the observed reductions in CXCL-10 suggest a nuclear event.
###end p 11
###begin p 12
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Hennig1">[17]</xref>
###xml 198 205 198 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 328 338 328 338 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figures 1E</bold>
###xml 328 338 328 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g001"><bold>figures 1E</bold></xref>
###xml 338 339 338 339 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 339 340 339 340 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</bold>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g002"><bold>2</bold></xref>
###xml 340 355 340 355 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and not shown).</bold>
###xml 551 561 543 553 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figures 1E</bold>
###xml 551 561 543 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g001"><bold>figures 1E</bold></xref>
###xml 561 562 553 554 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 562 572 554 564 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A, and 2B</bold>
###xml 562 572 554 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g002"><bold>2A, and 2B</bold></xref>
###xml 697 706 685 694 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 1E</bold>
###xml 697 706 685 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g001"><bold>figure 1E</bold></xref>
###xml 706 719 694 707 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and not shown</bold>
###xml 871 875 859 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Hennig1">[17]</xref>
###xml 1015 1024 995 1004 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 2A</bold>
###xml 1015 1024 995 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g002"><bold>figure 2A</bold></xref>
###xml 1142 1151 1114 1123 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 2A</bold>
###xml 1142 1151 1114 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g002"><bold>figure 2A</bold></xref>
###xml 1342 1351 1310 1319 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 2B</bold>
###xml 1342 1351 1310 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g002"><bold>figure 2B</bold></xref>
###xml 1515 1524 1483 1492 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 2C</bold>
###xml 1515 1524 1483 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g002"><bold>figure 2C</bold></xref>
###xml 273 276 <span type="species:ncbi:10116">rat</span>
###xml 489 492 <span type="species:ncbi:10116">rat</span>
###xml 496 501 <span type="species:ncbi:10090">mouse</span>
###xml 975 978 <span type="species:ncbi:10116">rat</span>
Pin1 can be selectively blocked by juglone (5-hydroxy-1,4-naphthoquinone), which covalently binds to and irreversibly inhibits Pin-1 activity but has no effect on CyA or FKBP [17]. Prior to its use in vivo, WT and KO thymocytes were activated with anti-CD3/anti-CD28 while rat splenocytes were treated with ionophore/PMA (I/P) (figures 1E,2and not shown). After 4 hours of I/P, cytokine mRNAs increased by as much as 500 fold (IFN-gamma. IFN-gamma and IL-2 mRNA levels were reduced in the rat or mouse WT cells by 70-95% after treatment with juglone (figures 1E,2A, and 2B). However, juglone had no significant effect on the abundance of IL-2, IFN-gamma or the housekeeping RNAs in Pin1 KO cells (figure 1Eand not shown), demonstrating the specificity of this drug. At the concentrations used here neither CyA nor FKBP12 peptidyl-prolyl isomerase activities are affected [17]. Juglone (1 microM) completely blocked the accumulation of I/P-induced IFN-gamma and IL-2 mRNAs by rat splenocytes without altering actin (figure 2A). At lower juglone concentrations (0.1 microM), only the accumulation of IFN-gamma mRNA was significantly inhibited (figure 2A). These data suggest a variable sensitivity of cytokine mRNAs to Pin1 inhibition. The accumulation of IL-2 and IFN-gamma after juglone were dramatically reduced in the culture supernatants (figure 2B). The failure to produce cytokines was not a function of cell death as equivalent levels of viability were observed in I/P versus I/P/juglone treated splenocytes (figure 2C).
###end p 12
###begin p 13
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Haque1">[18]</xref>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Sekine1">[19]</xref>
###xml 466 470 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Zhao1">[20]</xref>
###xml 471 475 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Reinders1">[24]</xref>
###xml 978 988 974 984 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">not shown)</bold>
###xml 1297 1305 1293 1301 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 3</bold>
###xml 1297 1305 1293 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g003"><bold>figure 3</bold></xref>
###xml 1426 1434 1422 1430 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 3</bold>
###xml 1426 1434 1422 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g003"><bold>figure 3</bold></xref>
###xml 1773 1781 1769 1777 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 3</bold>
###xml 1773 1781 1769 1777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g003"><bold>figure 3</bold></xref>
###xml 1931 1939 1927 1935 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 3</bold>
###xml 1931 1939 1927 1935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g003"><bold>figure 3</bold></xref>
###xml 2248 2262 2236 2250 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(not shown and</bold>
###xml 2262 2271 2250 2259 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 4A</bold>
###xml 2262 2271 2250 2259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g004"><bold>figure 4A</bold></xref>
###xml 2271 2272 2259 2260 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 2353 2354 2341 2342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2363 2367 2351 2355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Mizobuchi1">[25]</xref>
###xml 121 124 <span type="species:ncbi:10116">rat</span>
###xml 972 976 <span type="species:ncbi:10116">rats</span>
In order to characterize Pin1 function during an in vivo type I immune response, we used the widely employed F344 to WKY rat, MHC Class I mismatched, orthotopic, single lung transplantation model [18], [19]. The donor organ is attached via cuffs to the recipient's bronchial and vascular systems permitting normal function. Nonimmunosuppressed recipients experience profound acute rejection within several days largely mediated by IFN-gamma and CXCL-10 upregulation [20]-[24]. Over several weeks, chronic rejection occurs with alveolar, pleural, and peribronchial collagen deposition, loss of viable pneumocytes and eventual organ loss. Recipients were given a daily, single intraperitoneal (IP) injection of 1 mg/kg juglone dissolved in ethanol and diluted in 5 ml saline, while controls received diluents only. This doses of juglone had no effect on red cell mass, white cell counts, serum chemistries, liver function tests, or renal function in control, untransplanted rats (not shown). Therefore juglone administration appeared to be safe and nontoxic. Treatment was started the day of the transplant. At day 7 or 14, animals were sacrificed and the lungs evaluated grossly and by histopathology. In untreated animals, the transplant was visibly shrunken and the pleural surfaces hemorrhagic (figure 3). Palpation revealed a firm and unyielding consistency. The juglone treated animals showed no gross signs of rejection (figure 3) and was indistinguishable from the contralateral control. Microscopically, the untreated transplanted lung showed severe rejection with acute inflammatory cell infiltration predominantly composed of neutrophils, lymphocytes and macrophages. Alveolar architecture was totally effaced and the small airways packed with inflammatory cells (figure 3). These changes were completely absent in juglone treated animals, which showed normal alveolar architecture, pleural thickness, and airway patency (figure 3). Occasional round macrophages were present in some alveoli. No significant difference was found in the relative proportion of CD4, CD8 or gammadelta T cells in blood and BAL fluid from the native right lung or the transplanted left lung, 7 days after transplantation in juglone treated or untreated animals (not shown andfigure 4A). This is in contrast to collagen V tolerized animals that show predominantly CD4+ T cells [25]. These data demonstrate that Pin1 blockade can dramatically attenuate acute transplant rejection.
###end p 13
###begin p 14
###xml 114 123 110 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 4B</bold>
###xml 114 123 110 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g004"><bold>figure 4B</bold></xref>
###xml 263 272 259 268 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">not shown</bold>
###xml 598 607 590 599 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 4C</bold>
###xml 598 607 590 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g004"><bold>figure 4C</bold></xref>
###xml 725 734 713 722 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 4D</bold>
###xml 725 734 713 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g004"><bold>figure 4D</bold></xref>
###xml 858 869 846 857 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 5A&#8211;C</bold>
###xml 858 869 846 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g005"><bold>figure 5A&#8211;C</bold></xref>
###xml 944 948 932 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Shen1">[12]</xref>
###xml 852 856 <span type="species:ncbi:10116">rats</span>
One week after transplantation the levels of IFN-gamma, and IL-2 in the bronchoalveolar fluid (BAL) were reduced (figure 4B). These data suggest that Pin1 blockade prevented cytokine production by T cells, which were the majority population within the BAL fluid (not shown). Since draining lymph nodes are a predominant site for immunological reactivity we analyzed mediastinal lymph node cells for the expression of cytokine mRNAs by qPCR. mRNAs coding for IFN-gamma, IL-2, and CXCL-10 were significantly lower in juglone treated animals than controls whereas IL-4 was not significantly affected (figure 4C). IFN-gamma ELISPOTS of whole spleen showed large reductions in the juglone treated animals from untreated controls (figure 4D). At day 7, Pin1 PPIase activity and amount were attenuated in BAL cells and draining lymph nodes in juglone treated rats (figure 5A-C). Once inactivated by juglone, Pin1 is rapidly degraded by the proteasome [12]. Therefore, Pin1 inhibition prevented IFN-gamma, and IL-2 expression by T cells throughout the immune system and acute graft rejection after lung transplantation. The profound suppression of CXCL-10 presumably reflects both reductions in IFN-gamma, which normally induces CXCL-10 as well as direct effects of Pin1 on CXCL-10 expression.
###end p 14
###begin p 15
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Zhao1">[20]</xref>
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Hauser1">[21]</xref>
###xml 601 609 597 605 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 3</bold>
###xml 601 609 597 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g003"><bold>figure 3</bold></xref>
###xml 755 764 747 756 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">figure 5D</bold>
###xml 755 764 747 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g005"><bold>figure 5D</bold></xref>
###xml 874 883 866 875 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">not shown</bold>
###xml 102 108 <span type="species:ncbi:9606">humans</span>
###xml 456 459 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 678 682 <span type="species:ncbi:10116">rats</span>
The expression of these cytokines has been highly correlated with rejection in both animal models and humans [20], [21]. In order to demonstrate a causal role, IFN-gamma and CXCL-10 expression vectors were combined and insufflated into donor lungs immediately before religature in the recipient. To avoid potential Pin1 mediated, post-transcriptional regulation, only the coding region without the 3' UTR was inserted downstream of a constitutively active CMV promoter. By 1 week after transplant, the lung grafts underwent significant rejection in untreated controls, which was prevented by juglone (figure 3). The forced expression of IFN-gamma and CXCL-10 in juglone treated rats resulted in severe cellular infiltration irrespective of Pin1 blockade (figure 5D). Transgenic cytokines were detectable in the BAL at comparable levels to that seen in untreated recipients (not shown). These results support a central role of IFN-gamma and CXCL-10 in the process of acute rejection and suggest that cytokine suppression after Pin1 inhibition is likely responsible for graft sparing.
###end p 15
###begin p 16
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Duncan1">[26]</xref>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Duncan1">[26]</xref>
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Duncan1">[26]</xref>
###xml 1018 1022 1018 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Pierog1">[27]</xref>
###xml 1115 1123 1115 1123 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6</bold>
###xml 1115 1123 1115 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g006"><bold>Figure 6</bold></xref>
###xml 1261 1269 1261 1269 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6</bold>
###xml 1261 1269 1261 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g006"><bold>Figure 6</bold></xref>
###xml 1404 1412 1404 1412 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6</bold>
###xml 1404 1412 1404 1412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g006"><bold>Figure 6</bold></xref>
###xml 1558 1566 1558 1566 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6</bold>
###xml 1558 1566 1558 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g006"><bold>Figure 6</bold></xref>
###xml 943 947 <span type="species:ncbi:10116">rats</span>
Immunosuppressive drugs, particularly CsA greatly improves graft survival but have renal damage as a common side effect [26]. To avoid toxicity and enhance graft acceptance, immunosuppressants such as corticosteroids, calcineurin inhibitors, antimetabolites, and rapamycin are given in combination [26]. Cyclosporine A and tacrolimus indirectly inhibit nuclear factor of T cells (NFAT) preventing the transcriptional upregulation of cytokine genes by activated T cells [26]. In contrast, Pin1 suppresses expression through the regulation of cytokine mRNA stability. Given this distinct mode of action, we asked if combined CsA and juglone therapy would be additive or synergistic. CsA was injected intraperitoneally for 3 days at a dose of 1 mg/kg together with 0.1 mg/kg of juglone, which was then continued alone for 4 more days. Cyclosporine is usually used at 25 mg/kg/day for 3 days which induces long lived lung transplant acceptance in rats while moderate to severe rejection was observed at doses of 5 mg/kg/d [27]. Transplanted animals treated with CsA alone (1 mg/kg/d) showed modest graft discoloration (Figure 6) but microscopically severe cellular infiltration diffusely throughout the parenchyma with foci in peribronchial and perivascular areas (Figure 6). Similarly, suboptimal inhibition of Pin1 leads to severe rejection pathology with substantial cellular infiltration and hemorrhage (Figure 6). In contrast, combined suboptimal treatment with CsA and juglone provided excellent graft protection without identifiable cellular infiltrates (Figure 6). These data show that combined inhibition of Pin1 and calcineurin are additive or synergistic and suggest that CsA dosage could be signifcantly reduced if Pin1 inhibition is added to the therapeutic regiment.
###end p 16
###begin title 17
Discussion
###end title 17
###begin p 18
###xml 522 526 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Shen1">[12]</xref>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Esnault1">[13]</xref>
###xml 686 694 686 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 953 960 945 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1072 1080 1064 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1090 1097 1082 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1326 1330 1318 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Esnault1">[13]</xref>
###xml 1434 1438 1426 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Shen1">[12]</xref>
###xml 1440 1444 1432 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Esnault1">[13]</xref>
###xml 1446 1453 1438 1445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 1680 1684 1668 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Lu2">[16]</xref>
###xml 1743 1747 1731 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Esnault1">[13]</xref>
###xml 756 760 <span type="species:ncbi:10116">rats</span>
###xml 988 992 <span type="species:ncbi:10116">rats</span>
We recently reported that Pin1 plays a role in the post-transcriptional control of GM-CSF mRNA expression by activated eosinophils and lymphocytes. Mechanistically, Pin1 interacts with and controls the ARE mRNA-binding activity of AUF1. When associated with AUF1, ARE mRNAs such as GM-CSF are rapidly catabolized by the exosome preventing translation. Cell activation rapidly increased Pin1 activity leading to AUF1 isomerization and loss of mRNA binding. Under these conditions, GM-CSF mRNA was stabilized and translated [12], [13]. These data suggested that other cytokine mRNAs, particularly those with AREs in their 3' untranslated region might be similarly regulated. Here we show in vitro, using either Pin1 KO or juglone-treated splenocytes from WT rats that Pin1 activity is required to stabilize, accumulate and translate mRNAs coding for several type-1 cytokines including IFN-gamma and IL-2. These effects on IFN-gamma and IL-2 were observed in vivo after juglone treatment of rats receiving MHC Class I mismatched, orthotopic, single lung transplants. CXCL-10 in vitro and IL-4 in vivo mRNA levels were far less affected by Pin1 blockade, suggesting Pin1 regulates only the most labile AU-rich mRNAs. These results are in agreement with our previous study showing IL-4 expression is insensitive to Pin1 inhibition [13], and reinforces the conclusion that Pin1 affects mRNA levels specifically through ARE-binding proteins [12], [13]. In vivo, the profound suppression of CXCL-10 observed presumably reflects both reductions in IFN-gamma, which normally induces CXCL-10 as well as direct effects of Pin1 on the production of CXCL-10, which might include nuclear events [16]. Finally, incomplete Pin1 blockade using low dose juglone [13] failed to decrease IL-2 mRNA levels but significantly reduced protein secretion. Therefore, in addition to stabilization and transcription, Pin1 may affect the of ARE mRNAs as well.
###end p 18
###begin p 19
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Gothel1">[28]</xref>
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Hennig1">[17]</xref>
###xml 447 455 447 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 543 544 539 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 580 584 576 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Hennig1">[17]</xref>
###xml 670 674 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Hennig1">[17]</xref>
###xml 1112 1116 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Chao1">[29]</xref>
###xml 1444 1451 1424 1431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 533 538 <span type="species:ncbi:4932">yeast</span>
###xml 543 550 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 1602 1606 <span type="species:ncbi:10090">mice</span>
Pin1 differs from CyA and FKBP12 in uniquely recognizing phosphorylated Ser/Thr-Pro motifs via a group IV WW domain and its PPIase is structurally distinct [28]. Unlike CyA and FKBP12, Pin1 is sensitive to juglone, which irreversibly binds to cysteines within the isomerase domain [17]. Enzymatic assays herein demonstrated that Pin1 activity in cell lysates most proximal to allostimulation (BAL and mediastinal nodes) was completely suppressed. In vitro, 5.7 microM juglone eliminated essentially 100% of Pin1's and highly related yeast and E. coli parvulin isomerases activity [17]. Importantly, these juglone concentrations had no effect on cyclophilin A nor FKBP12 [17]. Assuming complete distribution throughout all body water, the 1 mg/kg dose of juglone used here should generate a maximal concentration of approximately10 microM. Therefore, it is very unlikely that cyclophilin A nor FKBP12 were affected by juglone treatment and underlie the graft acceptance seen here. While juglone has been shown to affect other enzymes including RNA polymerase, pyruvate decarboxylase and glutathione S-transferase [29], none of these has been implicated in the selective expression of the subset of cytokine mRNAs downregulated in these experiments. Were these enzymes or polymerases inhibited, global rather than selective downregulation of gene expression would be expected. Therefore, we conclude that the immunosuppressive effects of juglone in vivo reflect Pin1 blockade. In addition, the specificity of juglone on IFN-gamma and IL-2 expression through Pin1 has been confirmed using T cells from KO mice. Indeed, juglone did not affect IFN-gamma and IL-2 expression in activated T cells from these animals. Importantly, these doses of juglone were nontoxic. Neither renal, hematology nor liver function tests showed abnormalities after treatment for 2 weeks. While it is unlikely juglone would be employed clinically, these data are encouraging for the development of additional Pin1 inhibitors.
###end p 19
###begin p 20
###xml 610 614 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Zhao1">[20]</xref>
###xml 616 620 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Hauser1">[21]</xref>
###xml 622 626 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Agostini1">[30]</xref>
###xml 710 714 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Hancock1">[22]</xref>
###xml 799 803 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Hancock2">[31]</xref>
###xml 928 932 920 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-vanBesouw1">[32]</xref>
###xml 933 937 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Hodge1">[34]</xref>
###xml 1041 1045 1029 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Nickel2">[35]</xref>
###xml 1647 1652 1621 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 555 560 <span type="species:ncbi:9606">human</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 884 889 <span type="species:ncbi:9606">human</span>
Irrespective of molecular mechanism, suppression of Pin1 clearly prevented acute and chronic graft rejection. Most prominently absent were inflammatory cells and compensatory alveolar, pleural and bronchial fibrosis. Based on our data, we favor three explanations for graft survival after Pin1 inhibition. First, the production or expression of critical, proinflammatory chemokines (CXCL-10) and cytokines (IFN-gamma and IL-2) containing 3' untranslated region AREs were markedly attenuated. CXCL-10 levels have been well correlated with the rejection by human recipients of renal, cardiac and lung allografts [20], [21], [30]. Cardiac allografts were not rejected if derived from CXCL-10 deficient donor mice [22] nor if wild type organs were transplanted into CXCL-10 receptor knockout recipients [31]. Similarly, IFN-gamma and CXCL-10 have been highly associated with rejection in human cardiac and lung allograft recipients [32]-[34] and the appearance of IFN-gamma positive splenocytes predicted the onset of renal transplant rejection [35]. Therefore, IFN-gamma and CXCL-10 appear particularly important for T cell chemotaxis into and propensity to initiate an anti-graft response. This was directly tested here by constitutive overexpression of IFN-gamma and CXCL-10 within the graft and demonstration that Pin1 blockade was unable to prevent immune cell infiltration and rejection. Finally, the lack of chronic rejection and collagen deposition observed here may reflect a role of Pin1 in TGF-beta1 production or signalling to fibroblasts. TGF-beta1 induced collagen III mRNA was significantly reduced by escalating doses of juglone (Shen et al., manuscript submitted). The mechanism underlying this observation is unknown but presumably involves Smad signalling. These data suggest Pin1 blockade could be effective in reducing the fibrosis characteristic of BOS, which is seen despite immunosuppression with CsA, steroids and other agents.
###end p 20
###begin p 21
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Shen1">[12]</xref>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Esnault1">[13]</xref>
The identification of Pin1 as a potential target for immunosuppression could have considerable importance. Most currently employed drugs have been available for 15 years or more and despite combined therapy, continue to have significant side-effects. Based on the data here and previously [12], [13], Pin1's regulation of immune responses involves post-transcriptional pathways largely unaffected by CsA or FK506. Therefore, we tested if CsA plus juglone showed additive effects. Indeed, combined therapy with suboptimal doses of CsA and juglone showed dramatic inhibition of graft rejection, demonstrating that these agents could be used together with effectiveness and possibly lower toxicity.
###end p 21
###begin p 22
###xml 339 343 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Shen1">[12]</xref>
###xml 345 349 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Esnault1">[13]</xref>
The data presented here show that Pin1 influences the type I immune response by modulating the production of proinflammatory, T cell cytokines including IFN-gamma and IL-2. Based on prior work, Pin1 likely functions through direct interactions with and regulation of key AUUUA specific, mRNA binding proteins such as AUF1, HnRNP C and HuR [12], [13]. Interference with Pin1 through pharmacologic or genetic means reduced IFN-gamma and IL-2 production and substantially attenuated graft rejection. Our data predict that drug combinations directed at the production (CsA, FK506, steroids) and decay of cytokine mRNAs would more effectively suppress alloimmunity and do so with reduced toxicity. More generally, the broad range of type 1 immune responses such as infectious diseases (intra and extracellular pathogens) or autoimmunity (diabetes, multiple sclerosis and lupus) that involve or require IFN-gamma suggest a role for Pin1 in these processes as well.
###end p 22
###begin title 23
Materials and Methods
###end title 23
###begin title 24
Reagents
###end title 24
###begin p 25
Juglone (5-hydroxy-1,4-naphthoquinone), ethanol, ionomycin and phorbol myristate acetate (PMA) were from Sigma (Sigma-Aldrich Chemical Company, St. Louis, MO), isoflurane was from Phoenix Pharmaceutical Inc. (St. Joseph, MO). Anti-CD3-coated plates, control plates and the anti-CD28 antibody were provided by BD Biosciences, Bedford, MA. Cyclosporine A was purchased from Gallipot, Inc. (St. Paul, MN) through the hospital pharmacy.
###end p 25
###begin title 26
###xml 9 13 <span type="species:ncbi:10090">mice</span>
Pin1 -/- mice
###end title 26
###begin p 27
###xml 228 231 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">Mice</span>
###xml 359 364 <span type="species:ncbi:10090">mouse</span>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 1237 1241 <span type="species:ncbi:10090">mice</span>
Pin1 null mice were originally generated by Fujimori, and the Pin1 deletion was transferred into an isogenic C57BL/6J background by Jackson Laboratory. Dr. Anthony Means of Duke University Medical Center generously provided Pin1+/- mice to our laboratory. Mice were housed 2-4 per microisolator cage on a 6am-6pm light cycle with ad libitum food (Purina 5015 mouse diet) and water. The cages contained seeds and a neslet as the only sources of environmental enrichment. All husbandry and euthanasia procedures were performed in accordance with NIH and an approved University of Wisconsin Madison animal care protocol through the Research Animal Resources Center. As homozygous Pin1 mutant mice are infertile, heterozygote mice were mated to generate WT, heterozygote and knock-out progeny. Genotypes were determined by PCR analysis of DNA extracted from tail biopsies taken at the time of weaning (postnatal day 18). The forward 5'-ATCATCCTGCGCACAGAATG-3' and reverse 5'-TCAATTCCTCCAGAAGGAGC-3' primers for the WT pin1 allele and the forward 5'-CTTGGGTGGAGAGGCTATTC-3' and reverse 5'-AGGTGAGATGACAGGAGATC-3' primers for the disrupted allele produced 195 and 280 nt PCR products, respectively. Thymus and spleen were dissected from adult mice (12 weeks old). Splenocyte and thymocyte suspensions were prepared using cell strainers from BD Bioscience (San Jose, CA). Red blood cells were lysed with ammonium chloride.
###end p 27
###begin title 28
Transplantation
###end title 28
###begin p 29
###xml 722 726 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Sekine1">[19]</xref>
###xml 986 993 980 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en bloc</italic>
###xml 85 89 <span type="species:ncbi:10116">rats</span>
###xml 315 319 <span type="species:ncbi:10116">rats</span>
###xml 364 367 <span type="species:ncbi:10116">Rat</span>
###xml 372 377 <span type="species:ncbi:10090">Mouse</span>
###xml 737 741 <span type="species:ncbi:10116">rats</span>
###xml 913 916 <span type="species:ncbi:10116">rat</span>
###xml 1178 1181 <span type="species:ncbi:10116">rat</span>
All experiments were carried out under an approved animal protocol with F344 and WKY rats weighing 300-350 g (Harlan, Indianapolis, IN). The animals were housed with 2-3 animals per cage that were maintained in environmentally controlled rooms at 22degreesC and 50-55% humidity, with a 12/12h light/dark cycle. All rats were fed a standard laboratory diet (NIH-07 Rat and Mouse Chow) and were provided water ad libitum. The animal resource services facilities are accredited by the American Association for the Accreditation of Laboratory Animal Care. Animals were euthanized with an overdose of inhaled isoflurane. The orthotopic transplantation of left lung was performed as previously reported using the cuff technique [19]. Briefly: rats were anaesthetized by inhalation of a mixture of isoflurane and oxygen, intubated and ventilated with a mixture of isoflurane and oxygen to maintain anesthesia. The donor rat was placed in a supine position and the heart and lungs were removed en bloc. The left lung was resected and the pulmonary vein, bronchus, and pulmonary artery were passed through teflon cuffs and the proximal ends were everted over the cuffs. On the recipient rat a left thoracotomy was performed. The donor pulmonary vein, bronchus, and pulmonary artery were inserted into the corresponding recipient hilar structures, and fixed with separate circumferential ligatures of silk. The chest wall was closed, and the isoflurane was stopped.
###end p 29
###begin title 30
Juglone and cyclosporine preparation and injection
###end title 30
###begin p 31
Juglone was dissolved in 100% ethanol at 14 mM (2.44 mg/ml). For injection between 100 and 150 microl of this solution (depending on the animal weight) was diluted in 5 ml saline and injected i.p. within 30 minutes. For suboptimal dosing between 10 and 25 microl of this solution was injected. Control animals received weight appropriate volume (100-150 microl; 10-25 microl resp.) of 100% ethanol in 5 ml saline. Cyclosporine A was dissolved in 100% ethanol at 25 mg/ml. For injection 10 to 25 microl of this solution (depending on the animal weight) was diluted in 5 ml saline and injected prior to the transplantation and the two following days.
###end p 31
###begin title 32
Preparation of lung, lymph nodes and blood
###end title 32
###begin p 33
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en bloc</italic>
###xml 274 275 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
After sacrifice blood was drawn from the abdominal vein into a heparinized tube. BAL was performed separately in the left transplanted lung and the right native lung. Lungs were then remove en bloc and fixed by bronchial infusion of a 1% paraformaldehyde solution at 30 cm H2O pressure overnight. Mediastinal lymph nodes and spleen were removed and cell suspensions were prepared using cell strainers from BD Bioscience (San Jose, CA). Red blood cells were lysed with ammonium chloride.
###end p 33
###begin title 34
Pin1 activity assay
###end title 34
###begin p 35
###xml 46 50 46 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Shen1">[12]</xref>
###xml 52 56 52 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Esnault1">[13]</xref>
Activity was measured as described previously [12], [13]. White blood cells from lymph node, spleen, and bronchoalveolar lavage fluid were lysed by repeated freeze-thaw cycles in a buffer containing 50 mM HEPES and 100 mM NaCl, pH 7.0. Total protein (10 microg in 10 microl) was mixed with 70 microl of HEPES-NaCl buffer supplemented with 2 mM dithiothreitol and 0.04 mg/ml BSA. Then, 5 microl of alpha-chymotrypsin (60 microg/microl in 0.001 N HCl) was added and mixed throughly. Finally, 5 microl of the tetrapeptide substrate Suc-Ala-Glu-Pro-Phe-pNa (Peptides International, Louisville, Kentucky) dissolved in dimethylsulfoxide and preincubated at a concentration of 100 microg/ml in 480 mM LiCl and trifluoroethanol, was added. Absortion at 390 nm was measured over 30 min with a Beckman Coulter DU 800 spectrophotometer.
###end p 35
###begin title 36
Cytokine mRNA analysis
###end title 36
###begin p 37
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000226-Esnault1">[13]</xref>
###xml 1156 1169 1119 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;CT</sup>
###xml 1096 1099 <span type="species:ncbi:10116">Rat</span>
###xml 1109 1114 <span type="species:ncbi:10090">mouse</span>
For the measurement of mRNA steady state levels in immune cells, 2x105 to 1x106 cells were lysed in TRI reagent (Molecular Research Center, Cincinnati, OH) and processed as already described [13]. Total RNA was extracted as described by the manufacturer. The synthesis of first strain cDNA was performed using the manufacturer's protocol (Qiagen Inc. Valencia, CA). Briefly, total RNA was resuspended in a final volume of 20 microl containing 4 units of Omniscript, 2 microl of 10x RT buffer, 2 microl of 5 mM dNTP, 20 units of RNase inhibitor and 1 microl of random hexamer primers (27 OD/microl) (Invitrogen, Carlsbad, CA) and incubated at 37degreesC for 60 min. 1/10 to 1/20 of the RT products were used for the real time PCR (qPCR). The primers were selected using the Primer Express software and the SYBR green master mix from Applied Biosystems was used as recommended by the manufacturer. For each set of primers, the efficiency of the PCR was determined after serial dilutions of the cDNA. The PCR efficiencies were > 90% and allowed the DeltaDeltaCT calculations relative to beta-actin (Rat) or 18S (mouse) in order to calculate the fold change (2-DeltaDeltaCT) in mRNA steady state levels between juglone-treated or untreated groups.
###end p 37
###begin title 38
ELISPOT and ELISA
###end title 38
###begin p 39
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
###xml 172 176 <span type="species:ncbi:10116">rats</span>
IFN-gamma measurements in the mouse splenocyte cultures were determined using an EKISA kit (Biosource, Camarillo, CA). IFN-gamma secretion by splenocytes from transplanted rats was evaluated by ELISPOT (R&D Systems, Minneapolis, MN) as described by the manufacturer. Triplicates of serial dilutions of cells were cultured with PMA (10 ng/ml) plus iononycin (1 microM) for 48 hours. The concentration of IFN-gamma and IL-2 in the BAL fluid was determined using an ELISA kit (R&D Systems, Minneapolis, MN). Lavage fluid was concentrated 10 fold prior to analysis. Lavage recovery was similar in all animals and the data shown are those from the concentrated samples.
###end p 39
###begin title 40
IFN-gamma and CXCL-10 expression vectors
###end title 40
###begin p 41
pcDNA1 (InVitrogen) was opened at Xba 1 and Xho 1 sites and PCR products coding for the coding regions of IFN-gamma and CXCL-10 inserted via sticky end ligation using standard methods. Putative clones were sequenced to ensure full length insert was present in the appropriate orientation. After amplification, plasmids were precipitated, washed and resuspended in sterile TE at 1 mg/ml and 100 microl used for insufflation.
###end p 41
###begin title 42
Splenocyte survival
###end title 42
###begin p 43
The survival of resting, ionomycin plus PMA (I/P) without or with juglone at 1 (I/P/J1) or 0.1 microM (I/P/J0.1)-treated splenocytes were determined by propidium iodide staining and flow cytometry at 24 hours after the beginning of the culture.
###end p 43
###begin title 44
Statistics
###end title 44
###begin p 45
1-sample t-tests were used for statistical analysis of the data.
###end p 45
###begin p 46
###xml 127 132 <span type="species:ncbi:10090">mouse</span>
The authors wish to thank members of the UW-SCOR-asthma group for their helpful comments. We thank Cara Westmark for providing mouse spleens and thymus. We also thank Emily Whitesel for her technical assistance.
###end p 46
###begin title 47
References
###end title 47
###begin article-title 48
Dynamic regulation of IFN-gamma signaling in antigen-specific CD8+ T cells responding to infection.
###end article-title 48
###begin article-title 49
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human allograft arterial injury is ameliorated by sirolimus and cyclosporine and correlates with suppression of interferon-gamma.
###end article-title 49
###begin article-title 50
Interferon-gamma: an overview of signals, mechanisms and functions.
###end article-title 50
###begin article-title 51
Regulation of lymphokine messenger RNA stability by a surface-mediated T cellactivation pathway.
###end article-title 51
###begin article-title 52
###xml 75 80 <span type="species:ncbi:9606">human</span>
Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells.
###end article-title 52
###begin article-title 53
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.
###end article-title 53
###begin article-title 54
Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage.
###end article-title 54
###begin article-title 55
Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins.
###end article-title 55
###begin article-title 56
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human peptidyl-prolyl isomerase essential for regulation of mitosis.
###end article-title 56
###begin article-title 57
Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.
###end article-title 57
###begin article-title 58
###xml 58 63 <span type="species:ncbi:9606">human</span>
The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.
###end article-title 58
###begin article-title 59
The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils.
###end article-title 59
###begin article-title 60
The peptidyl-prolyl isomerase Pin1 regulates granulocyte-macrophage colony-stimulating factor mRNA stability in T lymphocytes.
###end article-title 60
###begin article-title 61
A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.
###end article-title 61
###begin article-title 62
###xml 6 11 <span type="species:ncbi:9606">human</span>
ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins.
###end article-title 62
###begin article-title 63
Pinning down cell signaling, cancer and Alzheimer's disease.
###end article-title 63
###begin article-title 64
Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone.
###end article-title 64
###begin article-title 65
Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection.
###end article-title 65
###begin article-title 66
###xml 209 212 <span type="species:ncbi:10116">rat</span>
Role of passenger leukocytes in allograft rejection: effect of depletion of donor alveolar macrophages on the local production of TNF-alpha, T helper 1/T helper 2 cytokines, IgG subclasses, and pathology in a rat model of lung transplantation.
###end article-title 66
###begin article-title 67
###xml 178 183 <span type="species:ncbi:9606">human</span>
Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
###end article-title 67
###begin article-title 68
Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG).
###end article-title 68
###begin article-title 69
Donor-derived IP-10 initiates development of acute allograft rejection.
###end article-title 69
###begin article-title 70
Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients.
###end article-title 70
###begin article-title 71
Proinflammatory functions of vascular endothelial growth factor in alloimmunity.
###end article-title 71
###begin article-title 72
Differential expression of Smad7 transcripts identifies the CD4+CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts.
###end article-title 72
###begin article-title 73
Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.
###end article-title 73
###begin article-title 74
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 108 111 <span type="species:ncbi:10116">rat</span>
Synergistic effect of low dose cyclosporine A and human interleukin 10 overexpression on acute rejection in rat lung allotransplantation.
###end article-title 74
###begin article-title 75
Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts.
###end article-title 75
###begin article-title 76
Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription.
###end article-title 76
###begin article-title 77
CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection.
###end article-title 77
###begin article-title 78
Requirement of the chemokine receptor CXCR3 for acute allograft rejection.
###end article-title 78
###begin article-title 79
###xml 85 90 <span type="species:ncbi:9606">human</span>
The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantation.
###end article-title 79
###begin article-title 80
Early accumulation of interferon-gamma in grafts tolerized by donor-specific blood transfusion: friend or enemy?
###end article-title 80
###begin article-title 81
###xml 60 68 <span type="species:ncbi:9606">patients</span>
Intracellular cytokines in blood T cells in lung transplant patients-a more relevant indicator of immunosuppression than drug levels.
###end article-title 81
###begin article-title 82
Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients.
###end article-title 82
###begin title 83
Figures and Tables
###end title 83
###begin p 84
###xml 0 53 0 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cytokine expression is downregulated in Pin1&#8722;/&#8722; mouse</italic>
###xml 1211 1212 1181 1182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 88 90 <span type="species:ncbi:10090">KO</span>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 111 113 <span type="species:ncbi:10090">WT</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 864 866 <span type="species:ncbi:10090">KO</span>
###xml 867 871 <span type="species:ncbi:10090">mice</span>
###xml 907 911 <span type="species:ncbi:10090">mice</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
###xml 1266 1268 <span type="species:ncbi:10090">KO</span>
###xml 1284 1286 <span type="species:ncbi:10090">WT</span>
###xml 1288 1292 <span type="species:ncbi:10090">mice</span>
Cytokine expression is downregulated in Pin1-/- mouse. A/ Splenocytes from Pin1-/-mice (KO) or wild-type mice (WT) were activated for 3 hours with anti-CD3 plus anti-CD28. mRNAs for IFN-gamma, IL-2 or CXCL10 were analyzed by reverse transcription, qPCR. Fold change increase in activated compared to resting cells were assessed and averages+/-SD from 3 mice in each groups are presented. B/ Splenocytes were activated as in (A) for 5 hours and IFN-gamma amounts in the cultures were measured by ELISA. Averages+/-SD from 3 mice in each groups are presented. C/ Percentage of IFN-gamma and IL-2 positive CD4+ and CD8+ cells in splenocytes activated for 5 hours with anti-CD3. Splenocytes were incubated for 30 min at 4degreesC with relevant antibodies at saturation and then washed and analyzed using a FACSCalibur instrument (Becton Dickinson, Mountain View, CA). KO mice (-/-) are compared to heterozygote mice (+/-) and a representative experiment is shown D/ Splenocytes from the same mice (n = 3) were activated with anti-CD3 plus anti-CD28 for 3 hours before treated with actinomycin D (Act D;10 microg/ml). mRNA levels were determined by qPCR at the indicated times after Act D. IFN-gamma mRNA levels at T0 were normalized to 100%. E/ Thymocytes from Pin1-/- (KO) or wild-type (WT) mice were activated with anti-CD3 plus anti-CD28 for 3 hours with or without juglone (1 microM). mRNA levels were determined by qPCR and presented as relative (%) expression of IFN-gamma in juglone-treated cells compared to activated. * denotes p<0.05.
###end p 84
###begin p 85
###xml 0 78 0 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cytokine mRNAs are suppressed by Pin1 inhibition in activated rat splenocytes.</italic>
###xml 62 65 <span type="species:ncbi:10116">rat</span>
###xml 737 740 <span type="species:ncbi:10116">rat</span>
Cytokine mRNAs are suppressed by Pin1 inhibition in activated rat splenocytes. A/ mRNAs for IFN-gamma, IL-2, and CXCL-10 were analyzed in splenocytes by reverse transcription, qPCR. Cells were cultured for 4 hours without activation (resting), or with ionophore plus PMA (I/P) or I/P plus juglone (I/P/J) at 1 or 0.1 microM. The ionomycin/PMA stimulated sample was normalized to 100 and others expressed as a % of that value. The data are averages+/-SEM of 3 independent experiments using splenocytes of untreated healthy animals. B/ Secreted IFN-gamma and IL-2 after 24 hours from the cultures as described in (A). The data are averages+/-SEM of 3 independent experiments using splenocytes of untreated healthy animals. C/ Viability of rat splenocytes treated as above for 24 hr, incubated with propidium iodine and analyzed by flow cytometry.
###end p 85
###begin p 86
###xml 0 49 0 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pin1 is required for acute and chronic rejection.</italic>
Pin1 is required for acute and chronic rejection. I and IV: Gross appearance of lungs from control, untreated transplants (I) and juglone treated (1 mg/kg) (IV). Lungs are oriented so that transplant is on the left. II and V: Hematoxylin and eosin stained sections from control untreated (II) or juglone treated (V) 1 week after transplant. III and VI: Trichrome stained sections of control, untreated (III) and juglone treated (VI) two weeks after transplant. These are representative sections from 8 control and 8 juglone treated transplant recipients in each set.
###end p 86
###begin p 87
###xml 0 38 0 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#947; and IL-2 are Pin1 dependent.</italic>
###xml 984 1004 958 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and Methods</xref>
###xml 201 205 <span type="species:ncbi:10116">rats</span>
###xml 838 842 <span type="species:ncbi:10116">rats</span>
IFN-gamma and IL-2 are Pin1 dependent. A/ Relative percentage of CD4, CD8 and gammadelta T lymphocytes in BAL cells from the transplanted lung. BAL cells were prepared from control and juglone-treated rats as described above and the percentage of CD4+, CD8+ and gammadelta T lymphocytes were determined by flow cytometry with specific antibodies. The graph represents an average +/- SD of 4 experiments. B/ IFN-gamma and IL-2 concentrations in concentrated BAL fluid were determined by ELISA. * denotes p<0.01. C/ Mediastinal lymph nodes from control or juglone treated animals were used for reverse transcription, qPCR for the cytokines shown along the x-axis. The values in untreated controls were normalized to 100% and data shown represent % change in juglone treated samples. In (B) and (C), the data shown are an average+/-SEM of 4 rats in each group 7 days after transplantation. * denotes p<0.05 from control samples. D/ Splenocytes were isolated and cultured as described in Material and Methods. IFN-gamma positive splenocytes were quantitated by Elispot (n = 3). * denotes p<0.05.
###end p 87
###begin p 88
###xml 0 120 0 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression of exogenous IFN-&#947; and CXCL-10 in juglone-treated rats overcomes Pin1 inhibition and results in rejection</italic>
###xml 316 324 295 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 65 69 <span type="species:ncbi:10116">rats</span>
Expression of exogenous IFN-gamma and CXCL-10 in juglone-treated rats overcomes Pin1 inhibition and results in rejection. A/ BAL fluid cells from transplanted and untreated controls (), or juglone treated (black triangle) were quantitated, lysed and used for Pin1 isomerase assay. Juglone (1 microM) was also added in vitro to equal amounts of the control (open diamond) and juglone treated (triangle up) samples and isomerase assay repeated. B/ Mediastinal lymph nodes from 2 untreated controls (,open diamond) or one juglone treated animal (black triangle) were lysed and equal amounts of protein used for Pin1 isomerase assay. C/ Immunoblot with anti-Pin1 or anti-actin of mediastinal lymph nodes from 2 controls, untreated (-juglone) or 2 juglone treated animals (+juglone). D/ Donor lungs were insufflated with 100 microg each of CXCL10 and IFN-gammaexpression vectors immediately prior to religation in recipient. Animals were then untreated (I, II) or treated with juglone at 1mg/kg for 1 week (III, IV) and histopathologic analysis after H & E staining. Representative sections from multiple animals shown.
###end p 88
###begin p 89
###xml 0 48 0 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pin1 and calcineurin inhibition are synergistic.</italic>
###xml 83 91 83 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000226-g003">figure 3</xref>
Pin1 and calcineurin inhibition are synergistic. Transplants were performed as for figure 3 and animals harvested 7 days later. (I) Treated with CsA at 1 mg/kg/d for 3 days. (II) Treated with juglone at 0.1 mg/kg/d for 7 days. (III) Treated with CsA at 1 mg/kg/d for 3 days plus juglone at 0.1 mg/kg/d for 7 days. For all conditions, gross apearance of the transplant at harvest shown along the left, 5x and 20x representative sections stained with H & E shown in the middle and right panels.
###end p 89
###begin p 90
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 90
###begin p 91
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: NIH (P50HL56396 to J.S.M.) and the Department of Surgery (to R.K.B.).
###end p 91

